Covid-19 Impact on Contraceptives Drugs and Devices Market, Global Research Reports 2020-2021

This report covers market size and forecasts of Contraceptives Drugs and Devices, including the following market information:

    Global Contraceptives Drugs and Devices Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)

    Global Contraceptives Drugs and Devices Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

Key market players

Major competitors identified in this market include Teva Pharmaceutical Industries Ltd, Church & Dwight Co. Inc, Reckitt Benckiser Plc, Pfizer, Inc, Bayer AG, Mayer Laboratories, Inc, The Female Health Company, Cooper Surgical, Inc, Allergan plc, Cipla Limited, Merck & Co. Inc, etc.

Based on the Region:

    Asia-Pacific (China, Japan, South Korea, India and ASEAN)

    North America (US and Canada)

    Europe (Germany, France, UK and Italy)

    Rest of World (Latin America, Middle East & Africa)

Based on the Type:

    Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)

    Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)

Based on the Application:

    Female

    Male

1.1 Research Scope

1.2 Market Segmentation

1.3 Research Objectives

1.4 Research Methodology

1.4.1 Research Process

1.4.2 Data Triangulation

1.4.3 Research Approach

1.4.4 Base Year

1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.5.2 Covid-19 Impact: Commodity Prices Indices

1.5.3 Covid-19 Impact: Global Major Government Policy

1.6 The Covid-19 Impact on Contraceptives Drugs and Devices Industry

1.7 COVID-19 Impact: Contraceptives Drugs and Devices Market Trends

2.1 Contraceptives Drugs and Devices Business Impact Assessment - COVID-19

2.1.1 Global Contraceptives Drugs and Devices Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.1.2 Global Contraceptives Drugs and Devices Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.2 Global Contraceptives Drugs and Devices Quarterly Market Size 2020-2021

2.3 COVID-19-Driven Market Dynamics and Factor Analysis

2.3.1 Drivers

2.3.2 Restraints

2.3.3 Opportunities

2.3.4 Challenges

3.1 Global Contraceptives Drugs and Devices Quarterly Market Size by Manufacturers, 2019 VS 2020

3.2 Global Contraceptives Drugs and Devices Factory Price by Manufacturers

3.3 Location of Key Manufacturers Contraceptives Drugs and Devices Manufacturing Factories and Area Served

3.4 Date of Key Manufacturers Enter into Contraceptives Drugs and Devices Market

3.5 Key Manufacturers Contraceptives Drugs and Devices Product Offered

3.6 Mergers & Acquisitions, Expansion Plans

4.1 Introduction

1.4.1 Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)

1.4.2 Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)

4.2 By Type, Global Contraceptives Drugs and Devices Market Size, 2019-2021

4.2.1 By Type, Global Contraceptives Drugs and Devices Market Size by Type, 2020-2021

4.2.2 By Type, Global Contraceptives Drugs and Devices Price, 2020-2021

5.1 Overview

5.5.1 Female

5.5.2 Male

5.2 By Application, Global Contraceptives Drugs and Devices Market Size, 2019-2021

5.2.1 By Application, Global Contraceptives Drugs and Devices Market Size by Application, 2019-2021

5.2.2 By Application, Global Contraceptives Drugs and Devices Price, 2020-2021

6.1 Introduction

6.2 North America

6.2.1 Macroeconomic Indicators of US

6.2.2 US

6.2.3 Canada

6.3 Europe

6.3.1 Macroeconomic Indicators of Europe

6.3.2 Germany

6.3.3 France

6.3.4 UK

6.3.5 Italy

6.4 Asia-Pacific

6.4.1 Macroeconomic Indicators of Asia-Pacific

6.4.2 China

6.4.3 Japan

6.4.4 South Korea

6.4.5 India

6.4.6 ASEAN

6.5 Rest of World

6.5.1 Latin America

6.5.2 Middle East and Africa

7.1 Teva Pharmaceutical Industries Ltd

7.1.1 Teva Pharmaceutical Industries Ltd Business Overview

7.1.2 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Quarterly Production and Revenue, 2020

7.1.3 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product Introduction

7.1.4 Teva Pharmaceutical Industries Ltd Response to COVID-19 and Related Developments

7.2 Church & Dwight Co. Inc

7.2.1 Church & Dwight Co. Inc Business Overview

7.2.2 Church & Dwight Co. Inc Contraceptives Drugs and Devices Quarterly Production and Revenue, 2020

7.2.3 Church & Dwight Co. Inc Contraceptives Drugs and Devices Product Introduction

7.2.4 Church & Dwight Co. Inc Response to COVID-19 and Related Developments

7.3 Reckitt Benckiser Plc

7.3.1 Reckitt Benckiser Plc Business Overview

7.3.2 Reckitt Benckiser Plc Contraceptives Drugs and Devices Quarterly Production and Revenue, 2020

7.3.3 Reckitt Benckiser Plc Contraceptives Drugs and Devices Product Introduction

7.3.4 Reckitt Benckiser Plc Response to COVID-19 and Related Developments

7.4 Pfizer, Inc

7.4.1 Pfizer, Inc Business Overview

7.4.2 Pfizer, Inc Contraceptives Drugs and Devices Quarterly Production and Revenue, 2020

7.4.3 Pfizer, Inc Contraceptives Drugs and Devices Product Introduction

7.4.4 Pfizer, Inc Response to COVID-19 and Related Developments

7.5 Bayer AG

7.5.1 Bayer AG Business Overview

7.5.2 Bayer AG Contraceptives Drugs and Devices Quarterly Production and Revenue, 2020

7.5.3 Bayer AG Contraceptives Drugs and Devices Product Introduction

7.5.4 Bayer AG Response to COVID-19 and Related Developments

7.6 Mayer Laboratories, Inc

7.6.1 Mayer Laboratories, Inc Business Overview

7.6.2 Mayer Laboratories, Inc Contraceptives Drugs and Devices Quarterly Production and Revenue, 2020

7.6.3 Mayer Laboratories, Inc Contraceptives Drugs and Devices Product Introduction

7.6.4 Mayer Laboratories, Inc Response to COVID-19 and Related Developments

7.7 The Female Health Company

7.7.1 The Female Health Company Business Overview

7.7.2 The Female Health Company Contraceptives Drugs and Devices Quarterly Production and Revenue, 2020

7.7.3 The Female Health Company Contraceptives Drugs and Devices Product Introduction

7.7.4 The Female Health Company Response to COVID-19 and Related Developments

7.8 Cooper Surgical, Inc

7.8.1 Cooper Surgical, Inc Business Overview

7.8.2 Cooper Surgical, Inc Contraceptives Drugs and Devices Quarterly Production and Revenue, 2020

7.8.3 Cooper Surgical, Inc Contraceptives Drugs and Devices Product Introduction

7.8.4 Cooper Surgical, Inc Response to COVID-19 and Related Developments

7.9 Allergan plc

7.9.1 Allergan plc Business Overview

7.9.2 Allergan plc Contraceptives Drugs and Devices Quarterly Production and Revenue, 2020

7.9.3 Allergan plc Contraceptives Drugs and Devices Product Introduction

7.9.4 Allergan plc Response to COVID-19 and Related Developments

7.10 Cipla Limited

7.10.1 Cipla Limited Business Overview

7.10.2 Cipla Limited Contraceptives Drugs and Devices Quarterly Production and Revenue, 2020

7.10.3 Cipla Limited Contraceptives Drugs and Devices Product Introduction

7.10.4 Cipla Limited Response to COVID-19 and Related Developments

7.11 Merck & Co. Inc

7.11.1 Merck & Co. Inc Business Overview

7.11.2 Merck & Co. Inc Contraceptives Drugs and Devices Quarterly Production and Revenue, 2020

7.11.3 Merck & Co. Inc Contraceptives Drugs and Devices Product Introduction

7.11.4 Merck & Co. Inc Response to COVID-19 and Related Developments

8.1 Contraceptives Drugs and Devices Supply Chain Analysis

8.1.1 Contraceptives Drugs and Devices Supply Chain Analysis

8.1.2 Covid-19 Impact on Contraceptives Drugs and Devices Supply Chain

8.2 Distribution Channels Analysis

8.2.1 Contraceptives Drugs and Devices Distribution Channels

8.2.2 Covid-19 Impact on Contraceptives Drugs and Devices Distribution Channels

8.2.3 Contraceptives Drugs and Devices Distributors

8.3 Contraceptives Drugs and Devices Customers

10.1 About Us

10.2 Disclaimer

List of Tables

    Table 1. Overview of the World Economic Outlook Projections

    Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

    Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

    Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

    Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

    Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

    Table 7. Covid-19 Impact: Global Major Government Policy

    Table 8. The Covid-19 Impact on Contraceptives Drugs and Devices Assessment

    Table 9. COVID-19 Impact: Contraceptives Drugs and Devices Market Trends

    Table 10. COVID-19 Impact Global Contraceptives Drugs and Devices Market Size

    Table 11. Global Contraceptives Drugs and Devices Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)

    Table 12. Global Contraceptives Drugs and Devices Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)

    Table 13. Global Contraceptives Drugs and Devices Quarterly Market Size, 2020 (US$ Million) & (K Units)

    Table 14. Global Contraceptives Drugs and Devices Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

    Table 15. Global Contraceptives Drugs and Devices Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)

    Table 16. Global Contraceptives Drugs and Devices Market Growth Drivers

    Table 17. Global Contraceptives Drugs and Devices Market Restraints

    Table 18. Global Contraceptives Drugs and Devices Market Opportunities

    Table 19. Global Contraceptives Drugs and Devices Market Challenges

    Table 20. Key Manufacturers Contraceptives Drugs and Devices Quarterly Revenue, 2019 VS 2020 (US$ Million)

    Table 21. Top Manufacturers, Contraceptives Drugs and Devices Market Size, 2019 (K Units) & (US$ Million)

    Table 22. Contraceptives Drugs and Devices Factory Price by Manufacturers 2020 (USD/Unit)

    Table 23. Location of Key Manufacturers Contraceptives Drugs and Devices Manufacturing Plants

    Table 24. Key Manufacturers Contraceptives Drugs and Devices Market Served

    Table 25. Date of Key Manufacturers Enter into Contraceptives Drugs and Devices Market

    Table 26. Key Manufacturers Contraceptives Drugs and Devices Product Type

    Table 27. Mergers & Acquisitions, Expansion Plans

    Table 28. Global Contraceptives Drugs and Devices Market Size by Type, 2020, (US$ Million)

    Table 29. Global Contraceptives Drugs and Devices Market Size by Type, 2020 (K Units)

    Table 30. Global Contraceptives Drugs and Devices Price: by Type, 2020-2021 (USD/Unit)

    Table 31. Global Contraceptives Drugs and Devices Market Size by Application: 2020-2021 (US$ Million)

    Table 32. Global Contraceptives Drugs and Devices Market Size by Application, 2020-2021 (K Units)

    Table 33. Global Contraceptives Drugs and Devices Price: by Application, 2020-2021 (USD/Unit)

    Table 34. Global Contraceptives Drugs and Devices Market Size by Region, 2019-2021 (US$ Million)

    Table 35. Global Contraceptives Drugs and Devices Market Size by Region, 2019-2021 (K Units)

    Table 36. By Country, North America Contraceptives Drugs and Devices Market Size, 2019-2021 (US$ Million)

    Table 37. By Country, North America Contraceptives Drugs and Devices Market Size, 2019-2021 (K Units)

    Table 38. US Contraceptives Drugs and Devices Market Size, 2019-2021 (US$ Million) & (K Units)

    Table 39. Canada Contraceptives Drugs and Devices Market Size, 2019-2021 (US$ Million) & (K Units)

    Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

    Table 41. By Country, Europe Contraceptives Drugs and Devices Market Size, 2019-2021 (US$ Million)

    Table 42. By Country, Europe Contraceptives Drugs and Devices Market Size, 2019-2021 (K Units)

    Table 43. Germany Contraceptives Drugs and Devices Market Size, 2019-2021 (US$ Million) & (K Units)

    Table 44. France Contraceptives Drugs and Devices Market Size, 2019-2021 (US$ Million) & (K Units)

    Table 45. UK Contraceptives Drugs and Devices Market Size, 2019-2021 (US$ Million) & (K Units)

    Table 46. Italy Contraceptives Drugs and Devices Market Size, 2019-2021 (US$ Million) & (K Units)

    Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

    Table 48. By Region, Asia-Pacific Contraceptives Drugs and Devices Market Size, 2019-2021 (US$ Million)

    Table 49. By Region, Asia-Pacific Contraceptives Drugs and Devices Market Size, 2019-2021 (K Units)

    Table 50. China Contraceptives Drugs and Devices Market Size, 2019-2021 (US$ Million) & (K Units)

    Table 51. Japan Contraceptives Drugs and Devices Market Size, 2019-2021 (US$ Million) & (K Units)

    Table 52. South Korea Contraceptives Drugs and Devices Market Size, 2019-2021 (US$ Million) & (K Units)

    Table 53. India Contraceptives Drugs and Devices Market Size, 2019-2021 (US$ Million) & (K Units)

    Table 54. ASEAN Contraceptives Drugs and Devices Market Size, 2019-2021 (US$ Million) & (K Units)

    Table 55. Latin America Contraceptives Drugs and Devices Market Size, 2019-2021 (US$ Million) & (K Units)

    Table 56. Middle East and Africa Contraceptives Drugs and Devices Market Size, 2019-2021 (US$ Million) & (K Units)

    Table 57. Teva Pharmaceutical Industries Ltd Business Overview

    Table 58. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 59. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product

    Table 60. Teva Pharmaceutical Industries Ltd Response to COVID-19 and Related Developments

    Table 61. Church & Dwight Co. Inc Business Overview

    Table 62. Church & Dwight Co. Inc Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 63. Church & Dwight Co. Inc Contraceptives Drugs and Devices Product

    Table 64. Church & Dwight Co. Inc Response to COVID-19 and Related Developments

    Table 65. Reckitt Benckiser Plc Business Overview

    Table 66. Reckitt Benckiser Plc Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 67. Reckitt Benckiser Plc Contraceptives Drugs and Devices Product

    Table 68. Reckitt Benckiser Plc Response to COVID-19 and Related Developments

    Table 69. Pfizer, Inc Business Overview

    Table 70. Pfizer, Inc Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 71. Pfizer, Inc Contraceptives Drugs and Devices Product

    Table 72. Pfizer, Inc Response to COVID-19 and Related Developments

    Table 73. Bayer AG Business Overview

    Table 74. Bayer AG Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 75. Bayer AG Contraceptives Drugs and Devices Product

    Table 76. Bayer AG Response to COVID-19 and Related Developments

    Table 77. Mayer Laboratories, Inc Business Overview

    Table 78. Mayer Laboratories, Inc Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 79. Mayer Laboratories, Inc Contraceptives Drugs and Devices Product

    Table 80. Mayer Laboratories, Inc Response to COVID-19 and Related Developments

    Table 81. The Female Health Company Business Overview

    Table 82. The Female Health Company Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 83. The Female Health Company Contraceptives Drugs and Devices Product

    Table 84. The Female Health Company Response to COVID-19 and Related Developments

    Table 85. Cooper Surgical, Inc Business Overview

    Table 86. Cooper Surgical, Inc Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 87. Cooper Surgical, Inc Contraceptives Drugs and Devices Product

    Table 88. Cooper Surgical, Inc Response to COVID-19 and Related Developments

    Table 89. Allergan plc Business Overview

    Table 90. Allergan plc Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 91. Allergan plc Contraceptives Drugs and Devices Product

    Table 92. Allergan plc Response to COVID-19 and Related Developments

    Table 93. Cipla Limited Business Overview

    Table 94. Cipla Limited Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 95. Cipla Limited Contraceptives Drugs and Devices Product

    Table 96. Cipla Limited Response to COVID-19 and Related Developments

    Table 97. Merck & Co. Inc Business Overview

    Table 98. Merck & Co. Inc Contraceptives Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 99. Merck & Co. Inc Contraceptives Drugs and Devices Product

    Table 100. Merck & Co. Inc Response to COVID-19 and Related Developments

    Table 101. Contraceptives Drugs and Devices Distributors List

    Table 102. Contraceptives Drugs and Devices Customers List

    Table 103. Covid-19 Impact on Contraceptives Drugs and Devices Customers

List of Figures

    Figure 1. Contraceptives Drugs and Devices Product Picture

    Figure 2. Contraceptives Drugs and Devices Market Segmentation

    Figure 3. Research Objectives

    Figure 4. Research Process

    Figure 5. Data Triangulation

    Figure 6. Research Approach

    Figure 7. Commodity Prices-Metals Price Indices

    Figure 8. Commodity Prices- Precious Metal Price Indices

    Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

    Figure 10. Commodity Prices- Food and Beverage Price Indices

    Figure 11. Commodity Prices- Fertilizer Price Indices

    Figure 12. Commodity Prices- Energy Price Indices

    Figure 13. G20+: Economic Policy Responses to COVID-19

    Figure 14. Global Contraceptives Drugs and Devices Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

    Figure 15. Global Contraceptives Drugs and Devices Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

    Figure 16. Global Contraceptives Drugs and Devices Market Size, Quarterly Growth, 2020-2021 (%)

    Figure 17. Global Contraceptives Drugs and Devices Market Size, Market Share by Type, 2019 VS 2020 (%)

    Figure 18. Global Contraceptives Drugs and Devices Market Size, Market Share by Application, 2019 VS 2020 (%)

    Figure 19. Global Contraceptives Drugs and Devices Market Size Market Share by Region, 2019 VS 2020 (%)

    Figure 20. United States Composite PMI and GDP

    Figure 21. Eurozone Composite PMI and GDP

    Figure 22. Eurozone Core v. Periphery PMI Output Indices

    Figure 23. Core v. Periphery PMI Employment Indices

    Figure 24. UK Composite PMI and GDP

    Figure 25. Caixin China Composite Output Index

    Figure 26. Caixin China General Services Business Activity Index

    Figure 27. Japan Composite Output Index

    Figure 28. South Korea Manufacturing PMI

    Figure 29. India Composite Output Index

    Figure 30. ASEAN Manufacturing PMI

    Figure 31. By Region, Asia-Pacific Contraceptives Drugs and Devices Market Size Market Share, 2019-2021